Bausch + Lomb BLCO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Pharmaceuticals | $1.13B+4.1% | $1.08B+5.0% | $1.03B+3.3% | $997M+1.5% | $982M+1.3% | |
| Surgical | $908M+1.6% | $894M+2.1% | $876M+1.0% | $867M+0.8% | $860M+2.0% | |
| Vision Care | $2.98B+1.9% | $2.92B+1.9% | $2.87B+1.8% | $2.82B+2.0% | $2.76B+0.8% | |
| Total revenues by Product | ||||||
| Branded and Other Generics | $237M-2.1% | $242M+0.8% | $240M-4.4% | $251M-6.7% | $269M-4.3% | |
| Devices | $1.95B+1.7% | $1.92B+2.2% | $1.88B+1.6% | $1.85B+1.5% | $1.82B+1.3% | |
| OTC | $1.87B+1.9% | $1.84B+1.5% | $1.81B+1.9% | $1.77B+2.0% | $1.74B+0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch + Lomb break its business down?
- Bausch + Lomb (BLCO) reports total revenues by business across 3 parts — Pharmaceuticals, Surgical and Vision Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch + Lomb's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch + Lomb's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.